Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
- PMID: 39248274
- DOI: 10.1111/bjh.19716
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
Abstract
This Good Practice Paper provides recommendations for the use of advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma. It describes how advanced imaging contributes to optimal healthcare resource utilisation by in newly diagnosed and relapsed myeloma, and provides a perspective on future directions of myeloma imaging, including machine learning assisted reporting.
Keywords: FDG‐PET/CT; early diagnosis; imaging; multiple myeloma; whole body MRI.
© 2024 British Society for Haematology and John Wiley & Sons Ltd.
References
REFERENCES
-
- van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397:410–427.
-
- Bernstein ZS, Kim EB, Raje N. Bone disease in multiple myeloma: biologic and clinical implications. Cells. 2022;11:2308. https://doi.org/10.3390/cells11152308
-
- Terpos E, Ntanasis‐Stathopoulos I, Gavriatopoulou M, Dimopoulos MA. Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J. 2018;8:7.
-
- Terpos E, Kleber M, Engelhardt M, Zweegman S, Gay F, Kastritis E, et al. European Myeloma Network guidelines for the management of multiple myeloma‐related complications. Haematologica. 2015;100:1254–1266.
-
- Thorsteinsdottir S, Gislason G, Aspelund T, Sverrisdottir I, Landgren O, Turesson I, et al. Fractures and survival in multiple myeloma: results from a population‐based study. Haematologica. 2020;105:1067–1073.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical